Valuation: BrainsWay Ltd.

Market Cap 628M 0 546M 510M 468M 883M 59.89B 898M 6.01B 2.35B 29.87B 2.36B 2.31B 98.51B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 628M 0 546M 510M 468M 883M 59.89B 898M 6.01B 2.35B 29.87B 2.36B 2.31B 98.51B EV / Sales 2026 *
9.29x
EV / Sales 2027 * 7.6x
Free-Float
90.49%
Yield 2026 *
-
Yield 2027 * -
1 day-2.47%
1 week-4.97%
Current month-2.47%
1 month+2.12%
3 months-4.04%
6 months+30.77%
Current year+52.86%
1 week 4,380
Extreme 4380
4,898
1 month 4,212
Extreme 4212
5,165
Current year 3,080
Extreme 3080
5,165
1 year 1,973
Extreme 1973
5,165
3 years 435
Extreme 435
5,165
5 years 272
Extreme 272
5,165
10 years 272
Extreme 272
5,165
Manager TitleAgeSince
Chief Executive Officer 54 2023-02-12
Chief Tech/Sci/R&D Officer 56 2006-04-30
Director of Finance/CFO 50 2023-05-22
Director TitleAgeSince
Chairman 74 2002-12-31
Director/Board Member 70 2006-10-31
Director/Board Member 56 2019-06-16
Date Insider Type Main position Quantity % Market Cap.
3/18/26 Other

Director

37,500 0.0956%
3/18/26 Other

Chief Technology Officer

63,881 0.1629%
Change 5-day change 1-year change 3-year change Capi.($)
-2.47%-4.97%+138.49%+985.68% 640M
-0.05%+2.59%+23.97%+4.68% 212B
+1.29%+0.51%+0.21%-23.29% 137B
+6.25%+5.21%-22.29%+20.60% 125B
+3.64%+6.42%-54.06%-4.82% 69.46B
+3.20%+6.96%+11.96%+11.02% 49.56B
+6.10%+9.98%-15.77%-19.36% 47.2B
+1.03%+1.39%+23.17%+11.80% 39.08B
-0.68%+0.95%+29.08%+28.60% 37.05B
-3.38%+4.59%+109.34%+6.92% 30.97B
Average +0.98%+3.38%+24.41%+102.18% 74.82B
Weighted average by Cap. +1.22%+3.46%+5.20%+2.72%

Financials

2026 *2027 *
Net sales 67.65M 0 58.79M 54.89M 50.39M 95.01M 6.45B 96.67M 647M 253M 3.22B 254M 248M 10.61B 82.64M 0 71.83M 67.06M 61.56M 116M 7.88B 118M 791M 310M 3.93B 310M 304M 12.96B
Net income 12.42M 0 10.8M 10.08M 9.25M 17.45M 1.18B 17.75M 119M 46.54M 590M 46.66M 45.62M 1.95B 19.74M 0 17.15M 16.01M 14.7M 27.72M 1.88B 28.2M 189M 73.95M 938M 74.13M 72.49M 3.09B
Net Debt - -
Logo BrainsWay Ltd.
Brainsway Ltd is an Israel-based company engaged in the development and marketing of medical devices for the treatment of various neurological and psychopathological disorders. The Company primarily offers Transcranial Magnetic Stimulation (TMS) system, a medical device that enables direct non-invasive activation of deep brain structures. Its TMS system uses magnetic pulses to stimulate neurons and consequently modulates the physiological activity of the brain. TMS system is used in various clinical applications including: major depressive disorders, obsessive-compulsive disorder, smoking addiction and others various psychiatric, neurological, and addiction disorders.
Employees
129
Date Price Change Volume
26-08-03 ILA 4,777.00 -2.47% 84,444
26-07-31 ILA 4,898.00 +3.82% 72,131
26-07-30 ILA 4,718.00 +5.90% 84,104
26-07-29 ILA 4,455.00 -5.61% 100,985
26-07-28 ILA 4,720.00 -4.40% 80,498

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BWAY Stock